ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이오테크 협력 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 845억 9,000만 달러로 평가되었고, 2025년에는 943억 5,000만 달러에 달하고, CAGR 11.5%로 성장할 전망입니다. 이 사이의 성장은 신규 치료제에 대한 수요 증가, 연구개발비 증가, 만성질환의 만연, 규제의 복잡화, 첨단 생명공학 채택 확대 등이 배경에 있습니다.
바이오테크 협력 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 11.2%로 1,440억 6,000만 달러에 이를 것으로 전망됩니다. 예측기간 중 성장의 원동력은 바이오신흥기업에 대한 투자 확대, 지속가능하고 환경친화적인 바이오프로세스에 대한 수요 증가, 개별화의료에 대한 주목이 높아짐, 유전자 및 세포 치료제의 채택 확대, 비용 최적화의 요구가 높아지고 있습니다. 예측 기간의 주요 동향으로는 차세대 생물 제제 개발, 오믹스 데이터 통합, 디지털 건강 기술 도입, 약물 전달 시스템 혁신, 지속 가능한 바이오프로세스 발전 등이 있습니다.
개인화된 의료에 대한 수요 증가는 향후 몇 년간의 바이오테크 협력 시장 확대를 촉진할 것으로 예측됩니다. 맞춤형 의료는 치료 및 예방 전략을 개인별 유전자 프로파일, 라이프 스타일 및 환경에 맞게 조정하는 것입니다. 이러한 맞춤형 의료 도입의 급증은 유전적 돌연변이의 정확한 식별과 맞춤형 치료의 개발을 가능하게 하는 유전체학의 진보에 의한 점이 큽니다. 바이오테크 협력은 전문 지식과 혁신적인 기술을 결합하여 개별 환자를 대상으로 한 치료법의 개발을 가속화하고 이 발전에 중요한 역할을 합니다. 이러한 공동 연구는 연구 기간을 단축하고 새로운 치료의 성공률을 향상시키고 효능과 환자 결과를 모두 향상시킵니다. 예를 들어, 2024년 2월 맞춤형 의료연합(PMC)은 미국 식품의약국(FDA)이 2023년 26개 개별화 신약을 승인했다고 보고했습니다. 그 결과 맞춤형 의료 수요가 바이오테크 협력 시장의 성장을 이끌고 있습니다.
바이오테크 협력 시장의 각 사는 인공지능(AI) 구동형 약물 발견 플랫폼 등의 혁신적인 솔루션의 개발에 주력하여 신규 치료제의 동정을 가속화하여 연구개발 효율을 향상시키고 있습니다. AI 주도의 약물 발견 플랫폼은 고급 알고리즘과 머신러닝을 활용하여 생물학적 데이터를 분석하고, 약물과 표적의 상호작용을 예측하고, 새로운 치료법의 개발을 효율화합니다. 예를 들어, 2025년 1월 프랑스에 본사를 둔 바이오테크놀러지 기업 Iktos SAS는 독일에 본사를 둔 바이오테크놀러지 기업 Cube Biotech GmbH와 제휴해 비만, 당뇨병, 대사 기능장애 관련 지방성 간염(MASH) 등 심대사성 질환의 유망한 치료 표적인 아밀린 수용체를 표적으로 하는 새로운 저분자 작용제를 개발했습니다. 이 제휴는 Iktos사의 생성형 AI 구동형 약물 발견 플랫폼과 Cube Biotech사의 막 단백질 기술 및 단백질 안정화법에 관한 전문 지식을 조합한 것입니다. 이 제휴는 약물 발견 타임라인을 가속화하고, 성공률을 높이고, 과제가 되고 있는 막 단백질의 타겟팅을 개선하고, GLP-1 수용체 작용제 등의 현재의 치료법보다 효율적이고 비용 효과적인 치료법의 가능성을 제공하는 것을 목적으로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 바이오테크 협력 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 바이오테크 협력 시장 : 성장률 분석
세계의 바이오테크 협력 시장 실적 : 규모와 성장, 2019년-2024년
세계의 바이오테크 협력 시장 예측 : 규모와 성장, 2024년-2029년, 2034년
세계의 바이오테크 협력 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 바이오테크 협력 시장 : 콜라보레이션 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
연구개발 협업
라이선싱 계약
합작사업
M&A
기타 콜라보레이션
세계의 바이오테크 협력 시장 : 용도별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
약물발견
임상 연구
진단약
치료제
기타 용도
세계의 바이오테크 협력 시장 : 최종사용자별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
제약회사
바이오테크놀러지 기업
학술연구기관
기타 최종 사용자
세계의 바이오테크 협력 시장 : 세분화 연구 개발 콜라보레이션: 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
전임상 연구
임상시험
트랜스레이셔널 리서치
약물발견
세계의 바이오테크 협력 시장 : 세분화 라이선싱 계약, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
독점 라이선싱
비독점 라이선싱
라이선싱
아웃라이선싱
세계의 바이오테크 협력 시장 : 세분화 합작 사업, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
전략적 제휴
공동개발
공동 마케팅
기술공유
세계의 바이오테크 협력 시장 : 세분화 M&A, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
수평 합병
업계별 합병
콩그로말리트 합병
자산 인수
세계의 바이오테크 협력 시장 : 세분화 기타 콜라보레이션, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
연구 컨소시엄
관민 파트너십
학술 협업
수탁연구
제7장 지역별/국가별 분석
세계의 바이오테크 협력 시장 : 지역별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
세계의 바이오테크 협력 시장 : 국가별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
바이오테크 협력 시장 : 경쟁 구도
바이오테크 협력 시장 : 기업 프로파일
Johnson And Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck And Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bayer AG
Sanofi SA
Novartis AG
AstraZeneca plc
Bristol-Myers Squibb Company
GlaxoSmithKline plc
Eli Lilly And Company
Novo Nordisk A/S
Takeda Pharmaceutical Company Limited
Amgen Inc.
Gilead Sciences Inc.
CH Boehringer Sohn AG & Co. KG
CSL Limited.
Regeneron Pharmaceuticals Inc.
Vertex Pharmaceuticals Incorporated
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
바이오테크 협력 시장 2029년 : 새로운 기회를 제공하는 국가
바이오테크 협력 시장 2029년 : 새로운 기회를 제공하는 부문
바이오테크 협력 시장 2029년 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Biotech collaborations refer to strategic partnerships between biotechnology companies, research institutions, or other organizations aimed at jointly developing, researching, or commercializing biotechnological products and innovations. These collaborations facilitate the sharing of expertise, resources, and technologies to accelerate innovation, reduce risks, and bring advanced biotech solutions to market more efficiently.
The primary types of biotech collaborations are research and development collaborations, licensing agreements, joint ventures, mergers or acquisitions, and others. Research and development collaborations involve strategic partnerships between two or more organizations to jointly conduct scientific research and develop new products, technologies, or processes. These collaborations support applications such as drug discovery, clinical research, diagnostics, therapeutics, and others, and serve end users including pharmaceutical companies, biotechnology firms, academic and research institutes, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The biotech collaborations market research report is one of a series of new reports from The Business Research Company that provides biotech collaborations market statistics, including biotech collaborations industry global market size, regional shares, competitors with a biotech collaborations market share, detailed biotech collaborations market segments, market trends and opportunities, and any further data you may need to thrive in the biotech collaborations industry. This biotech collaborations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biotech collaborations market size has grown rapidly in recent years. It will grow from $84.59 billion in 2024 to $94.35 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth during the historic period was driven by increasing demand for novel therapeutics, rising research and development expenditure, growing prevalence of chronic diseases, expanding regulatory complexities, and higher adoption of advanced biotechnologies.
The biotech collaborations market size is expected to see rapid growth in the next few years. It will grow to $144.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth during the forecast period is fueled by growing investments in biotech startups, rising demand for sustainable and green bioprocesses, increased focus on personalized medicine, expanding adoption of gene and cell therapies, and a growing need for cost optimization. The primary trends in the forecast period include development of next-generation biologics, integration of omics data, incorporation of digital health technologies, innovation in drug delivery systems, and advancement of sustainable bioprocesses.
The growing demand for personalized medicine is expected to drive the expansion of the biotech collaborations market in the coming years. Personalized medicine tailors treatment and prevention strategies to an individual's unique genetic profile, lifestyle, and environment. This surge in personalized medicine adoption is largely due to advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments. Biotech collaborations play a crucial role in this progress by combining expertise and innovative technologies, accelerating the development of targeted therapies for individual patients. These collaborations reduce research timelines and improve the success rates of new treatments, enhancing both efficacy and patient outcomes. For example, in February 2024, the Personalized Medicine Coalition (PMC) reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant rise from the 12 approved in 2022. As a result, the demand for personalized medicine is driving growth in the biotech collaborations market.
Companies in the biotech collaborations market are focusing on developing innovative solutions, such as artificial intelligence (AI)-driven drug discovery platforms, to accelerate the identification of new therapeutics and improve research and development efficiency. AI-driven drug discovery platforms leverage advanced algorithms and machine learning to analyze biological data, predict drug-target interactions, and streamline the development of new treatments. For instance, in January 2025, Iktos S.A.S., a France-based biotechnology company, partnered with Cube Biotech GmbH, a Germany-based biotech company, to develop novel small molecule agonists targeting the amylin receptor, a promising therapeutic target for cardiometabolic disorders, including obesity, diabetes, and metabolic dysfunction-associated steatotic hepatitis (MASH). This collaboration combines Iktos' generative AI-driven drug discovery platform with Cube Biotech's expertise in membrane protein technology and protein stabilization methods. The partnership aims to accelerate drug discovery timelines, enhance success rates, and improve targeting of challenging membrane proteins, offering potential therapies that could be more efficient and cost-effective than current treatments, such as GLP-1 receptor agonists.
In December 2023, Pfizer Inc., a U.S.-based pharmaceutical company, acquired Seagen Inc. for $43 billion. This acquisition strengthens Pfizer's oncology portfolio, expands its pipeline of targeted cancer therapies, and positions the company for long-term growth in the oncology space. Seagen, a biopharmaceutical company based in the U.S., has established strategic collaborations to advance its oncology pipeline.
Major players in the biotech collaborations market are Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly And Company, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., C.H. Boehringer Sohn AG & Co. KG, CSL Limited., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, and Biogen Inc.
North America was the largest region in the biotech collaborations market in 2024. The regions covered in biotech collaborations report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biotech collaborations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biotech collaborations market includes revenues earned by entities through clinical trial services, licensing and technology transfer, manufacturing and contract development, regulatory and consulting services, and bioinformatics and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biotech Collaborations Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biotech collaborations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biotech collaborations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotech collaborations market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Collaboration Type: Research And Development Collaborations; Licensing Agreements; Joint Ventures; Mergers Or Acquisitions; Other Collaborations
2) By Application: Drug Discovery; Clinical Research; Diagnostics; Therapeutics; Other Applications
3) By End User: Pharmaceutical Companies; Biotechnology Firms; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Research And Development Collaborations: Preclinical Research; Clinical Trials; Translational Research; Drug Discovery
2) By Licensing Agreements: Exclusive Licensing; Non Exclusive Licensing; In Licensing; Out Licensing
3) By Joint Ventures: Strategic Alliance; Co Development; Co Marketing; Technology Sharing
4) By Mergers Or Acquisitions: Horizontal Merger; Vertical Merger; Conglomerate Merger; Acquisition Of Assets
5) By Other Collaborations: Research Consortium; Public Private Partnership; Academic Collaboration; Contract Research
Companies Mentioned: Johnson And Johnson; F. Hoffmann-La Roche Ltd.; Merck And Co. Inc.; Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Novartis AG; AstraZeneca plc; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly And Company; Novo Nordisk A/S; Takeda Pharmaceutical Company Limited; Amgen Inc.; Gilead Sciences Inc.; C.H. Boehringer Sohn AG & Co. KG; CSL Limited.; Regeneron Pharmaceuticals Inc.; Vertex Pharmaceuticals Incorporated; Biogen Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biotech Collaborations Market Characteristics
3. Biotech Collaborations Market Trends And Strategies
4. Biotech Collaborations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Biotech Collaborations Growth Analysis And Strategic Analysis Framework
5.1. Global Biotech Collaborations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Biotech Collaborations Market Growth Rate Analysis
5.4. Global Biotech Collaborations Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Biotech Collaborations Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Biotech Collaborations Total Addressable Market (TAM)
6. Biotech Collaborations Market Segmentation
6.1. Global Biotech Collaborations Market, Segmentation By Collaboration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research And Development Collaborations
Licensing Agreements
Joint Ventures
Mergers Or Acquisitions
Other Collaborations
6.2. Global Biotech Collaborations Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Discovery
Clinical Research
Diagnostics
Therapeutics
Other Applications
6.3. Global Biotech Collaborations Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Biotechnology Firms
Academic And Research Institutes
Other End-Users
6.4. Global Biotech Collaborations Market, Sub-Segmentation Of Research And Development Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Preclinical Research
Clinical Trials
Translational Research
Drug Discovery
6.5. Global Biotech Collaborations Market, Sub-Segmentation Of Licensing Agreements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Exclusive Licensing
Non Exclusive Licensing
In Licensing
Out Licensing
6.6. Global Biotech Collaborations Market, Sub-Segmentation Of Joint Ventures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Strategic Alliance
Co Development
Co Marketing
Technology Sharing
6.7. Global Biotech Collaborations Market, Sub-Segmentation Of Mergers Or Acquisitions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Horizontal Merger
Vertical Merger
Conglomerate Merger
Acquisition Of Assets
6.8. Global Biotech Collaborations Market, Sub-Segmentation Of Other Collaborations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Consortium
Public Private Partnership
Academic Collaboration
Contract Research
7. Biotech Collaborations Market Regional And Country Analysis
7.1. Global Biotech Collaborations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Biotech Collaborations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
